Lion Point Capital, LP Hedge Fund

CIK: 0001643354 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $19,099 (100.0% shares, 0.0% debt)

Holdings (19)

INSM INSMED INC 13.3%

Value ($000) $2,534 Shares 36,700 Est. Cost $21.50 Unrealized +235.0%

MIST MILESTONE PHARMACEUTICALS IN 12.7%

Value ($000) $2,421 Shares 1,025,806 Est. Cost $3.14 Unrealized -45.3%

GERN GERON CORP 9.3%

Value ($000) $1,770 Shares 500,000 Est. Cost $2.31 Unrealized +72.8%

ARDX ARDELYX INC 8.9%

Value ($000) $1,700 Shares 335,400 Est. Cost $1.61 Unrealized +242.5%

FENC FENNEC PHARMACEUTICALS INC 6.5%

Value ($000) $1,237 Shares 195,700 Est. Cost $8.27 Unrealized -38.0%

BBIO BRIDGEBIO PHARMA INC 5.8%

Value ($000) $1,106 Shares 40,300 Est. Cost $27.34 Unrealized -5.5%

MLYS MINERALYS THERAPEUTICS INC 5.1%

Value ($000) $972 Shares 79,000 Est. Cost $12.41 Unrealized +5.4%

KNSA KINIKSA PHARMACEUTICALS LTD 4.8%

Value ($000) $908 Shares 45,900 Est. Cost $18.73 Unrealized +21.8%

BHVN BIOHAVEN LTD 4.4%

Value ($000) $848 Shares 22,700 Est. Cost $38.91 Unrealized +19.9%

BNTC BENITEC BIOPHARMA INC 4.1%

Value ($000) $783 Shares 62,000 Est. Cost $9.63 Unrealized +12.1%

SNDX SYNDAX PHARMACEUTICALS INC 3.8%

Value ($000) $727 Shares 55,000 Est. Cost $20.81 Unrealized -17.8%

JSPR JASPER THERAPEUTICS INC 3.6%

Value ($000) $684 Shares 32,000 Est. Cost $17.76 Unrealized +17.2%

— AVADEL PHARMACEUTICALS PLC 3.5%

Value ($000) $673 Shares 64,000 Est. Cost $14.06 Unrealized —

IRON DISC MEDICINE INC 3.5%

Value ($000) $672 Shares 10,600 Est. Cost $49.93 Unrealized +15.8%

— BLUEBIRD BIO INC 3.4%

Value ($000) $658 Shares 78,912 Est. Cost $8.34 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 3.4%

Value ($000) $645 Shares 46,300 Est. Cost $10.13 Unrealized +8.1%

RGNX REGENXBIO INC 2.3%

Value ($000) $446 Shares 57,750 Est. Cost $15.56 Unrealized -39.7%

— SERES THERAPEUTICS INC 1.5%

Value ($000) $283 Shares 340,761 Est. Cost $6.30 Unrealized —

— SPRUCE BIOSCIENCES INC 0.2%

Value ($000) $32 Shares 75,000 Est. Cost $0.79 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INSM	INSMED INC	36,700	$2,534	13.3%	$21.50	+235.0%	COM PAR $.01	457669307
MIST	MILESTONE PHARMACEUTICALS IN	1,025,806	$2,421	12.7%	$3.14	-45.3%	COM	59935V107
GERN	GERON CORP	500,000	$1,770	9.3%	$2.31	+72.8%	COM	374163103
ARDX	ARDELYX INC	335,400	$1,700	8.9%	$1.61	+242.5%	COM	039697107
FENC	FENNEC PHARMACEUTICALS INC	195,700	$1,237	6.5%	$8.27	-38.0%	COM	31447P100
BBIO	BRIDGEBIO PHARMA INC	40,300	$1,106	5.8%	$27.34	-5.5%	COM	10806X102
MLYS	MINERALYS THERAPEUTICS INC	79,000	$972	5.1%	$12.41	+5.4%	COM	603170101
KNSA	KINIKSA PHARMACEUTICALS LTD	45,900	$908	4.8%	$18.73	+21.8%	ORD SHS CL A	G52694109
BHVN	BIOHAVEN LTD	22,700	$848	4.4%	$38.91	+19.9%	COM	G1110E107
BNTC	BENITEC BIOPHARMA INC	62,000	$783	4.1%	$9.63	+12.1%	COM NEW	08205P209
SNDX	SYNDAX PHARMACEUTICALS INC	55,000	$727	3.8%	$20.81	-17.8%	COM	87164F105
JSPR	JASPER THERAPEUTICS INC	32,000	$684	3.6%	$17.76	+17.2%	COM NEW	471871202
—	AVADEL PHARMACEUTICALS PLC	64,000	$673	3.5%	$14.06	—	COM SHS	G29687103
IRON	DISC MEDICINE INC	10,600	$672	3.5%	$49.93	+15.8%	COM	254604101
—	BLUEBIRD BIO INC	78,912	$658	3.4%	$8.34	—	COM NEW	09609G209
ARQT	ARCUTIS BIOTHERAPEUTICS INC	46,300	$645	3.4%	$10.13	+8.1%	COM	03969K108
RGNX	REGENXBIO INC	57,750	$446	2.3%	$15.56	-39.7%	COM	75901B107
—	SERES THERAPEUTICS INC	340,761	$283	1.5%	$6.30	—	COM	81750R102
—	SPRUCE BIOSCIENCES INC	75,000	$32	0.2%	$0.79	—	COM	85209E109